Literature DB >> 15223807

The uveitogenic potential of retinal S-antigen in horses.

Cornelia A Deeg1, Sven Reese, Hartmut Gerhards, Gerhild Wildner, Bernd Kaspers.   

Abstract

PURPOSE: To investigate the uveitogenic potential of retinal S-antigen (S-Ag) in horses.
METHODS: Horses were immunized subcutaneously with S-Ag or BSA as control antigen, emulsified in complete Freund's adjuvant. Simultaneously, Bordetella pertussis was given intravenously. Antigen specific T- and B-cell responses were analyzed in a 3-day interval. Disease development was judged clinically and histopathologically. Two identical booster immunizations were given every 4 weeks to test induction of recurrences.
RESULTS: T- and B-cell responses specific for S-Ag were observed in all immunized horses but were absent in control animals. However, uveitis developed in only one of five animals. Reimmunization with S-Ag did not lead to a uveitic relapse in this horse. All other horses of the S-Ag- and BSA-treated groups neither showed any signs of uveitis, nor had inflammatory infiltrates of the inner eye.
CONCLUSIONS: In contrast to interphotoreceptor retinoid-binding protein (IRBP), S-Ag is a weak autoantigen in horses. Even though S-Ag immunization leads to the activation of autoreactive T- and B-cells, infiltration of the inner eye and induction of uveitis are controlled in most horses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223807     DOI: 10.1167/iovs.03-1226

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Immunological and pathological investigations in equine experimental uveitis.

Authors:  Galina P Simeonova; Svetozar Z Krastev; Radostin S Simeonov
Journal:  Vet Res Commun       Date:  2016-06-25       Impact factor: 2.459

2.  Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis.

Authors:  Roxane L Degroote; Stefanie M Hauck; Barbara Amann; Sieglinde Hirmer; Marius Ueffing; Cornelia A Deeg
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

3.  Aquaporin 11, a regulator of water efflux at retinal Müller glial cell surface decreases concomitant with immune-mediated gliosis.

Authors:  Cornelia A Deeg; Barbara Amann; Konstantin Lutz; Sieglinde Hirmer; Karina Lutterberg; Elisabeth Kremmer; Stefanie M Hauck
Journal:  J Neuroinflammation       Date:  2016-04-23       Impact factor: 8.322

4.  Interaction of septin 7 and DOCK8 in equine lymphocytes reveals novel insights into signaling pathways associated with autoimmunity.

Authors:  Melanie Schauer; Kristina J H Kleinwort; Roxane L Degroote; Carmen Wiedemann; Elisabeth Kremmer; Stefanie M Hauck; Cornelia A Deeg
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

5.  Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis.

Authors:  Leonie Fingerhut; Leyla Yücel; Katrin Strutzberg-Minder; Maren von Köckritz-Blickwede; Bernhard Ohnesorge; Nicole de Buhr
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

6.  Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro.

Authors:  Anne L C Hoffmann; Stefanie M Hauck; Cornelia A Deeg; Roxane L Degroote
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

7.  Profound re-organization of cell surface proteome in equine retinal pigment epithelial cells in response to in vitro culturing.

Authors:  Christoph M Szober; Stefanie M Hauck; Kerstin N Euler; Kristina J H Fröhlich; Claudia Alge-Priglinger; Marius Ueffing; Cornelia A Deeg
Journal:  Int J Mol Sci       Date:  2012-10-31       Impact factor: 5.923

8.  Aberrant Migratory Behavior of Immune Cells in Recurrent Autoimmune Uveitis in Horses.

Authors:  Carmen Wiedemann; Barbara Amann; Roxane L Degroote; Tanja Witte; Cornelia A Deeg
Journal:  Front Cell Dev Biol       Date:  2020-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.